Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Gaynon

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studiesP S Gaynon, B C Bostrom, R J Hutchinson, et al.
Cancer|November 7, 1998
Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer GroupF M Uckun, J B Nachman, H N Sather, et al.
Cancer|February 6, 1998
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Leukemia & Lymphoma|April 28, 2000
Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer GroupF M Uckun, M G Sensel, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Blood|July 29, 1998
Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocationF M Uckun, K Herman-Hatten, M L Crotty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemiaN A Heerema, H N Sather, M G Sensel, et al.
Cancer|November 14, 1997
Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a reviewP S Gaynon, A A Desai, B C Bostrom, et al.
Blood|September 9, 1999
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studiesP S Gaynon, B C Bostrom, R J Hutchinson, et al.
Cancer|November 7, 1998
Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer GroupF M Uckun, J B Nachman, H N Sather, et al.
Cancer|February 6, 1998
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Leukemia & Lymphoma|April 28, 2000
Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer GroupF M Uckun, M G Sensel, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.
Blood|July 29, 1998
Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocationF M Uckun, K Herman-Hatten, M L Crotty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemiaN A Heerema, H N Sather, M G Sensel, et al.
Cancer|November 14, 1997
Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a reviewP S Gaynon, A A Desai, B C Bostrom, et al.
Blood|September 9, 1999
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer GroupN A Heerema, H N Sather, M G Sensel, et al.
Pageof 7